Editorial Note: This is the third in a RxISK Map series of posts – See Reformation Day and Here We Stand. These link closely to the RxISK Prize. There are two aspects to finding a cure for an adverse event. One is understanding the biology. The other is getting it established that the effect happens. […]
Editorial Note: Courtesy of Fast Forward, here is a 12 month follow up to Olanzapine Withdrawal: Sally’s Story; some good, some OK and some awful. Sounds and speech Twelve months later, I continue to have problems with my hearing. The serious sensitivity to sounds has settled a bit – so I don’t jump out of my […]
Editorial Note: How long does withdrawal last? How much overlap is there between antipsychotic, benzodiazepine and antidepressant withdrawal? This is the first of two posts covering these issues. All answers later this week in part two. For Antipsychotic Withdrawal – see also Carole’s Story. I was prescribed olanzapine 20 mg in 2001, as a mood […]
Editorial note: this post is by Dee Mangin …. just when you were looking at pancreatic cancer on Januvia and Byetta. Sugar sugar: Less is not more Most people with diabetes now have type 2 diabetes. But for most people the high blood sugar called type 2 diabetes is not a disease. It is a […]
After its launch in the late 1950s, Upjohn’s Orinase (tolbutamide) became the first blockbuster hypoglycemic (blood sugar lowering) drug. Its success was born of failure. It wasn’t a replacement for insulin. Even if used early, it didn’t stop people from becoming insulin dependent. But attempts to create an early use market led to a focus on […]
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkPrivacy policy
